Coppermoly Def (COYNA) Quote

New people are the least of your worries.

Lol

Krombacher

Any inspections would not be taking place if the data was not good enough for approval.
The FDA does inspections even if they are CRL'ing the BLA/NDA for lack of sufficient trial data. Have you never heard of companies cited for both failing inspections and the need for another trial?

Shopify had a solid quarter; is telling investors that AI played a role in their success.

I think you would Desert,.. care - if he was a stereotype Klingon; "prideful ruthlessness and brutality".

It was a tenuous thread for sure.

When good news comes we double or triple ..so we get to 6 or 7 dollars .great if you bought now or 5 years ago.the juice is gone if you bought at 7 dollars 2 1/2 years ago
When we were expecting $100 now we will be happy at what price.
Hope delayed make sick heart

I do think the current EM status becomes overwhelmingly contradictory to what goals are outlined within the consultant agreement.

The consultant agreement outlines several tasks...
"partner search, supply chain building"
"Analysis of the team composition and identificati

The main man - rent free

https://investorshub.advfn.com/uimage/uploads/2024/3/7/dgoetDRK.JPG

Disagree. It is a major factor in the price action, and the current price is artificially low as a result.

No run going into Q2 and no PPS increase AT Q2 release, WTF??

I agree. Chinese get things done fast.

The Hessenn case is very troubling for Matt because it involves the manufacture, storage, and shipping of those kiosks. All of which, Matt depicted on his social media feeds and used in his financials. He won’t be able to deny their existence and federal court requires a federal case lawyer to rep

tweet tweet dump dump....back to trips soon

10km00t🟩8km00t🟩ALJm00t 47Wins
JudgeFAV0RED$DBMM. Meaning the ruling? +1

Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. ORDER--------

pbs.twimg.com/media/GUVwxFhWMAACIKF?format=png&name=900x900

I can’t wait to see the fully diluted shares when the Q comes out (hopefully) next week.

Why greg Duncan stretching a lot of news such as partnership of fibromyalgia and Long covid data? feels like reverse split is imminent

PYYX - $3.05 - Nice earnings report out... 25 million in the float...

https://www.otcmarkets.com/stock/PYYX/news/story?e&id=2940888

https://www.sec.gov/ix?doc=/Archives/edgar/data/939930/000093993024000097/pyx-20240630.htm

https://stockhouse.com/news/press-releases/2024/08/06/rumble-joins-x-to-sue-advertising-cartel-that-allegedly-conspired-to-withhold

I like the early Q2 release. It takes away the pump and dump and now people have to decide to buy or not just on the numbers presented. So that’s about $45 Million in revs for half a year, $3.6 Million in cash, no debt and also $JFHE ticker soon and speculation of the numbers for the other divisions

Only opinion that counts here is that of FDA. And what's your explanation for the continued rabbit studies after MK lied about completion? And why he took several months to write up and submit results to FDA? Gotta go with Occam on this one.

Where is David (5%) to tell us just hold on and be patient and let them do their thing?

Both may co-exist, but manipulation is far from being the biggest issue with this biotech company. Remove the misrepresentations and uncertainties created by Anavex and any manipulation will be completely marginalised.

Very favorable coverage on LUMN by Carl( cnbc host) just now on CNBC. Mentioned recent run-up and 5biillion deal. Stuff to do, will check in later. 💰💰💰

“Violent crime was up under Donald Trump,” he said, before pausing for effect. “That’s not even counting the crimes he committed.”